Articles Tagged With:
HRSA Compliance Exposes Hospitals to Liability and Fines
The Health Resources and Services Administration program that reimbursed providers for COVID-19-related treatment for uninsured patients was instrumental in helping hospitals survive the pandemic without excessive financial losses. But the federal government is looking at how that money was obtained and whether it was spent properly.
Wheelchair Falls May Be Underestimated in Fall Reduction Programs
Falls from wheelchairs are a serious patient safety risk but may not receive enough attention in the overall effort to prevent falls. A focus on reducing wheelchair falls can substantially affect overall fall reduction.
Financial Effect of Fall Prevention Can Be Significant
Falls in a healthcare facility can have serious health consequences for the patient. This is reason enough to aggressively pursue a risk reduction program. However, the financial cost to the healthcare provider cannot be ignored, and those losses can be helpful in justifying the time, effort, and money spent on fall reduction.
New Tool Released for Investigating Diagnostic Errors
A new tool developed by the Agency for Healthcare Research and Quality promises to help risk managers and quality improvement professionals analyze adverse events involving diagnostic errors, still one of the most challenging patient safety issues.
Updated Guidance Provides Sense of Urgency to Improve Clinical Trial Diversity
Organizations must invest in research infrastructure to support investigators in enrolling and retaining diverse study populations.
Few People with Limited English Proficiency Participate in Stroke Studies
Rather than making the IRB processes more difficult for researchers who wish to include underrepresented populations in their study, IRBs should work with researchers to overcome obstacles.
New Guidance on Incorporating Patient-Reported Outcomes in Clinical Research
Patient-reported outcomes can be used to develop healthcare policy and regulatory decisions, and also to monitor symptoms to provide timely care tailored to the patient’s needs.
Ethics Consults During Pandemic Inform Preparation for Future Crises
Lessons learned on ethics consults during the COVID-19 pandemic carry important implications for future disasters.
Parents, IRBs Hold Different Views on Phase I Pediatric Oncology Trials
IRB members are more likely than the public to think the risks outweigh the potential medical benefits. Parents think about the possibility of caring for a child with severe cancer and no treatment alternatives. IRBs ensure trials are ethical and that pediatric subjects are not exposed to excessive risk.
Pain Researchers Are Engaging Patients as Partners
Pain researchers would benefit by enacting a comprehensive approach to patient engagement, perhaps engaging people with lived experience of chronic pain in developing study recruitment materials.